BlackRock Capital Allocation Trust
BlackRock Capital Allocation Trust (BCAT) Stock Competitors & Peer Comparison
See (BCAT) competitors and their performances in Stock Market.
Peer Comparison Table: Asset Management Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BCAT | $15.52 | +0.19% | 1.6B | 7.32 | $2.12 | +20.59% |
| VTSAX | $178.52 | +0.69% | 2.2T | 27.12 | $6.55 | +1.02% |
| VITSX | $178.55 | +0.69% | 2.2T | 27.12 | $6.55 | +1.32% |
| VSMPX | $334.95 | +0.69% | 2.2T | 27.12 | $12.29 | +1.13% |
| PMFLX | $10.01 | +0.10% | 1.9T | N/A | N/A | N/A |
| VOO | $685.55 | +0.40% | 1.6T | 28.04 | $24.45 | +1.04% |
| VFINX | $690.79 | +0.56% | 1.6T | 27.93 | $24.64 | +1.19% |
| VFFSX | $366.25 | +0.56% | 1.6T | 27.93 | $13.06 | N/A |
| VFIAX | $690.74 | +0.56% | 1.6T | 27.93 | $24.64 | +1.12% |
| IVV | $749.14 | +0.40% | 831.1B | 28.00 | $26.76 | +1.08% |
Stock Comparison
BCAT vs VTSAX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VTSAX has a market cap of 2.2T. Regarding current trading prices, BCAT is priced at $15.52, while VTSAX trades at $178.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VTSAX's P/E ratio is 27.12. In terms of profitability, BCAT's ROE is +0.13%, compared to VTSAX's ROE of +0.08%. Regarding short-term risk, BCAT is more volatile compared to VTSAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VTSAX's competition here
BCAT vs VITSX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VITSX has a market cap of 2.2T. Regarding current trading prices, BCAT is priced at $15.52, while VITSX trades at $178.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VITSX's P/E ratio is 27.12. In terms of profitability, BCAT's ROE is +0.13%, compared to VITSX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VITSX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VITSX's competition here
BCAT vs VSMPX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VSMPX has a market cap of 2.2T. Regarding current trading prices, BCAT is priced at $15.52, while VSMPX trades at $334.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VSMPX's P/E ratio is 27.12. In terms of profitability, BCAT's ROE is +0.13%, compared to VSMPX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VSMPX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VSMPX's competition here
BCAT vs PMFLX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, PMFLX has a market cap of 1.9T. Regarding current trading prices, BCAT is priced at $15.52, while PMFLX trades at $10.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas PMFLX's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to PMFLX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to PMFLX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check PMFLX's competition here
BCAT vs VOO Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VOO has a market cap of 1.6T. Regarding current trading prices, BCAT is priced at $15.52, while VOO trades at $685.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VOO's P/E ratio is 28.04. In terms of profitability, BCAT's ROE is +0.13%, compared to VOO's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to VOO. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check VOO's competition here
BCAT vs VFINX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VFINX has a market cap of 1.6T. Regarding current trading prices, BCAT is priced at $15.52, while VFINX trades at $690.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VFINX's P/E ratio is 27.93. In terms of profitability, BCAT's ROE is +0.13%, compared to VFINX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VFINX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VFINX's competition here
BCAT vs VFFSX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VFFSX has a market cap of 1.6T. Regarding current trading prices, BCAT is priced at $15.52, while VFFSX trades at $366.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VFFSX's P/E ratio is 27.93. In terms of profitability, BCAT's ROE is +0.13%, compared to VFFSX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to VFFSX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VFFSX's competition here
BCAT vs VFIAX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VFIAX has a market cap of 1.6T. Regarding current trading prices, BCAT is priced at $15.52, while VFIAX trades at $690.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VFIAX's P/E ratio is 27.93. In terms of profitability, BCAT's ROE is +0.13%, compared to VFIAX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VFIAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VFIAX's competition here
BCAT vs IVV Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, IVV has a market cap of 831.1B. Regarding current trading prices, BCAT is priced at $15.52, while IVV trades at $749.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas IVV's P/E ratio is 28.00. In terms of profitability, BCAT's ROE is +0.13%, compared to IVV's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to IVV. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check IVV's competition here
BCAT vs FXAIX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, FXAIX has a market cap of 793.2B. Regarding current trading prices, BCAT is priced at $15.52, while FXAIX trades at $260.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas FXAIX's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to FXAIX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to FXAIX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FXAIX's competition here
BCAT vs SPY Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, SPY has a market cap of 768.5B. Regarding current trading prices, BCAT is priced at $15.52, while SPY trades at $745.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas SPY's P/E ratio is 28.01. In terms of profitability, BCAT's ROE is +0.13%, compared to SPY's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to SPY. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check SPY's competition here
BCAT vs VXUS Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VXUS has a market cap of 634.2B. Regarding current trading prices, BCAT is priced at $15.52, while VXUS trades at $84.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VXUS's P/E ratio is 18.23. In terms of profitability, BCAT's ROE is +0.13%, compared to VXUS's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to VXUS. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check VXUS's competition here
BCAT vs VTSNX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VTSNX has a market cap of 633.9B. Regarding current trading prices, BCAT is priced at $15.52, while VTSNX trades at $181.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VTSNX's P/E ratio is 18.22. In terms of profitability, BCAT's ROE is +0.13%, compared to VTSNX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VTSNX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VTSNX's competition here
BCAT vs VTPSX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VTPSX has a market cap of 633.9B. Regarding current trading prices, BCAT is priced at $15.52, while VTPSX trades at $181.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VTPSX's P/E ratio is 18.22. In terms of profitability, BCAT's ROE is +0.13%, compared to VTPSX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VTPSX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VTPSX's competition here
BCAT vs VTIAX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VTIAX has a market cap of 629.1B. Regarding current trading prices, BCAT is priced at $15.52, while VTIAX trades at $45.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VTIAX's P/E ratio is 18.22. In terms of profitability, BCAT's ROE is +0.13%, compared to VTIAX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VTIAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VTIAX's competition here
BCAT vs VTI Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VTI has a market cap of 627.8B. Regarding current trading prices, BCAT is priced at $15.52, while VTI trades at $366.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VTI's P/E ratio is 27.24. In terms of profitability, BCAT's ROE is +0.13%, compared to VTI's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to VTI. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check VTI's competition here
BCAT vs QQQ Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, QQQ has a market cap of 443.2B. Regarding current trading prices, BCAT is priced at $15.52, while QQQ trades at $717.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas QQQ's P/E ratio is 35.01. In terms of profitability, BCAT's ROE is +0.13%, compared to QQQ's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to QQQ. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check QQQ's competition here
BCAT vs BMOP Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, BMOP has a market cap of 434.4B. Regarding current trading prices, BCAT is priced at $15.52, while BMOP trades at $24.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas BMOP's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to BMOP's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to BMOP. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check BMOP's competition here
BCAT vs VUG Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VUG has a market cap of 370.5B. Regarding current trading prices, BCAT is priced at $15.52, while VUG trades at $87.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VUG's P/E ratio is 35.92. In terms of profitability, BCAT's ROE is +0.13%, compared to VUG's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to VUG. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check VUG's competition here
BCAT vs VIGAX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VIGAX has a market cap of 365.3B. Regarding current trading prices, BCAT is priced at $15.52, while VIGAX trades at $270.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VIGAX's P/E ratio is 35.89. In terms of profitability, BCAT's ROE is +0.13%, compared to VIGAX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VIGAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VIGAX's competition here
BCAT vs VIGIX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VIGIX has a market cap of 365.3B. Regarding current trading prices, BCAT is priced at $15.52, while VIGIX trades at $270.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VIGIX's P/E ratio is 35.89. In terms of profitability, BCAT's ROE is +0.13%, compared to VIGIX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VIGIX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VIGIX's competition here
BCAT vs VIIIX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VIIIX has a market cap of 342B. Regarding current trading prices, BCAT is priced at $15.52, while VIIIX trades at $599.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VIIIX's P/E ratio is 27.93. In terms of profitability, BCAT's ROE is +0.13%, compared to VIIIX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VIIIX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VIIIX's competition here
BCAT vs VINIX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VINIX has a market cap of 342B. Regarding current trading prices, BCAT is priced at $15.52, while VINIX trades at $599.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VINIX's P/E ratio is 27.93. In terms of profitability, BCAT's ROE is +0.13%, compared to VINIX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VINIX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VINIX's competition here
BCAT vs GFFFX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, GFFFX has a market cap of 339B. Regarding current trading prices, BCAT is priced at $15.52, while GFFFX trades at $85.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas GFFFX's P/E ratio is 31.84. In terms of profitability, BCAT's ROE is +0.13%, compared to GFFFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to GFFFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check GFFFX's competition here
BCAT vs AGTHX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, AGTHX has a market cap of 338.9B. Regarding current trading prices, BCAT is priced at $15.52, while AGTHX trades at $85.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas AGTHX's P/E ratio is 32.63. In terms of profitability, BCAT's ROE is +0.13%, compared to AGTHX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to AGTHX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check AGTHX's competition here
BCAT vs GAFFX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, GAFFX has a market cap of 338.9B. Regarding current trading prices, BCAT is priced at $15.52, while GAFFX trades at $85.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas GAFFX's P/E ratio is 32.64. In terms of profitability, BCAT's ROE is +0.13%, compared to GAFFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to GAFFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check GAFFX's competition here
BCAT vs RGAGX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, RGAGX has a market cap of 338.9B. Regarding current trading prices, BCAT is priced at $15.52, while RGAGX trades at $86.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas RGAGX's P/E ratio is 32.64. In terms of profitability, BCAT's ROE is +0.13%, compared to RGAGX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RGAGX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RGAGX's competition here
BCAT vs GFAFX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, GFAFX has a market cap of 337.5B. Regarding current trading prices, BCAT is priced at $15.52, while GFAFX trades at $84.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas GFAFX's P/E ratio is 32.62. In terms of profitability, BCAT's ROE is +0.13%, compared to GFAFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to GFAFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check GFAFX's competition here
BCAT vs CGFAX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, CGFAX has a market cap of 337.5B. Regarding current trading prices, BCAT is priced at $15.52, while CGFAX trades at $84.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas CGFAX's P/E ratio is 32.63. In terms of profitability, BCAT's ROE is +0.13%, compared to CGFAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to CGFAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check CGFAX's competition here
BCAT vs VTMGX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VTMGX has a market cap of 307.2B. Regarding current trading prices, BCAT is priced at $15.52, while VTMGX trades at $22.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VTMGX's P/E ratio is 18.82. In terms of profitability, BCAT's ROE is +0.13%, compared to VTMGX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VTMGX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VTMGX's competition here
BCAT vs VTMNX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VTMNX has a market cap of 307.2B. Regarding current trading prices, BCAT is priced at $15.52, while VTMNX trades at $22.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VTMNX's P/E ratio is 18.82. In terms of profitability, BCAT's ROE is +0.13%, compared to VTMNX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VTMNX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VTMNX's competition here
BCAT vs VEA Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VEA has a market cap of 306.7B. Regarding current trading prices, BCAT is priced at $15.52, while VEA trades at $70.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VEA's P/E ratio is 18.79. In terms of profitability, BCAT's ROE is +0.13%, compared to VEA's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to VEA. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check VEA's competition here
BCAT vs VDIPX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VDIPX has a market cap of 304.3B. Regarding current trading prices, BCAT is priced at $15.52, while VDIPX trades at $35.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VDIPX's P/E ratio is 18.82. In terms of profitability, BCAT's ROE is +0.13%, compared to VDIPX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VDIPX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VDIPX's competition here
BCAT vs LACG Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, LACG has a market cap of 291.7B. Regarding current trading prices, BCAT is priced at $15.52, while LACG trades at $9.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas LACG's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to LACG's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to LACG. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check LACG's competition here
BCAT vs BALFX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, BALFX has a market cap of 279.6B. Regarding current trading prices, BCAT is priced at $15.52, while BALFX trades at $40.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas BALFX's P/E ratio is 26.21. In terms of profitability, BCAT's ROE is +0.13%, compared to BALFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to BALFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check BALFX's competition here
BCAT vs AMBFX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, AMBFX has a market cap of 279.6B. Regarding current trading prices, BCAT is priced at $15.52, while AMBFX trades at $40.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas AMBFX's P/E ratio is 26.21. In terms of profitability, BCAT's ROE is +0.13%, compared to AMBFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to AMBFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check AMBFX's competition here
BCAT vs CLBAX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, CLBAX has a market cap of 279.6B. Regarding current trading prices, BCAT is priced at $15.52, while CLBAX trades at $40.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas CLBAX's P/E ratio is 26.21. In terms of profitability, BCAT's ROE is +0.13%, compared to CLBAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to CLBAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check CLBAX's competition here
BCAT vs AFMBX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, AFMBX has a market cap of 279.6B. Regarding current trading prices, BCAT is priced at $15.52, while AFMBX trades at $40.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas AFMBX's P/E ratio is 26.22. In terms of profitability, BCAT's ROE is +0.13%, compared to AFMBX's ROE of +0.13%. Regarding short-term risk, BCAT is more volatile compared to AFMBX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check AFMBX's competition here
BCAT vs RLBGX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, RLBGX has a market cap of 278.9B. Regarding current trading prices, BCAT is priced at $15.52, while RLBGX trades at $40.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas RLBGX's P/E ratio is 26.22. In terms of profitability, BCAT's ROE is +0.13%, compared to RLBGX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RLBGX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RLBGX's competition here
BCAT vs ABALX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, ABALX has a market cap of 278.9B. Regarding current trading prices, BCAT is priced at $15.52, while ABALX trades at $40.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas ABALX's P/E ratio is 26.20. In terms of profitability, BCAT's ROE is +0.13%, compared to ABALX's ROE of +0.13%. Regarding short-term risk, BCAT is more volatile compared to ABALX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check ABALX's competition here
BCAT vs RGABX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, RGABX has a market cap of 265.6B. Regarding current trading prices, BCAT is priced at $15.52, while RGABX trades at $74.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas RGABX's P/E ratio is 31.72. In terms of profitability, BCAT's ROE is +0.13%, compared to RGABX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RGABX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RGABX's competition here
BCAT vs RGAAX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, RGAAX has a market cap of 260.7B. Regarding current trading prices, BCAT is priced at $15.52, while RGAAX trades at $73.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas RGAAX's P/E ratio is 31.72. In terms of profitability, BCAT's ROE is +0.13%, compared to RGAAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RGAAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RGAAX's competition here
BCAT vs GFACX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, GFACX has a market cap of 253.8B. Regarding current trading prices, BCAT is priced at $15.52, while GFACX trades at $71.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas GFACX's P/E ratio is 32.59. In terms of profitability, BCAT's ROE is +0.13%, compared to GFACX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to GFACX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check GFACX's competition here
BCAT vs SWVXX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, SWVXX has a market cap of 245.3B. Regarding current trading prices, BCAT is priced at $15.52, while SWVXX trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas SWVXX's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to SWVXX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to SWVXX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check SWVXX's competition here
BCAT vs FCTDX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, FCTDX has a market cap of 241.2B. Regarding current trading prices, BCAT is priced at $15.52, while FCTDX trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas FCTDX's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to FCTDX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to FCTDX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FCTDX's competition here
BCAT vs VTV Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VTV has a market cap of 240.9B. Regarding current trading prices, BCAT is priced at $15.52, while VTV trades at $210.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VTV's P/E ratio is 21.57. In terms of profitability, BCAT's ROE is +0.13%, compared to VTV's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to VTV. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check VTV's competition here
BCAT vs VVIAX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VVIAX has a market cap of 237.8B. Regarding current trading prices, BCAT is priced at $15.52, while VVIAX trades at $82.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VVIAX's P/E ratio is 21.38. In terms of profitability, BCAT's ROE is +0.13%, compared to VVIAX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VVIAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VVIAX's competition here
BCAT vs VO Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VO has a market cap of 216.7B. Regarding current trading prices, BCAT is priced at $15.52, while VO trades at $78.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VO's P/E ratio is 23.74. In terms of profitability, BCAT's ROE is +0.13%, compared to VO's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to VO. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check VO's competition here
BCAT vs VIMAX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VIMAX has a market cap of 214.7B. Regarding current trading prices, BCAT is priced at $15.52, while VIMAX trades at $386.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VIMAX's P/E ratio is 23.53. In terms of profitability, BCAT's ROE is +0.13%, compared to VIMAX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VIMAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VIMAX's competition here
BCAT vs VMCPX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VMCPX has a market cap of 214.7B. Regarding current trading prices, BCAT is priced at $15.52, while VMCPX trades at $421.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VMCPX's P/E ratio is 23.53. In terms of profitability, BCAT's ROE is +0.13%, compared to VMCPX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VMCPX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VMCPX's competition here
BCAT vs VMCIX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VMCIX has a market cap of 214.7B. Regarding current trading prices, BCAT is priced at $15.52, while VMCIX trades at $85.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VMCIX's P/E ratio is 23.53. In terms of profitability, BCAT's ROE is +0.13%, compared to VMCIX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VMCIX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VMCIX's competition here
BCAT vs ODIDX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, ODIDX has a market cap of 214.6B. Regarding current trading prices, BCAT is priced at $15.52, while ODIDX trades at $8.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas ODIDX's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to ODIDX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to ODIDX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check ODIDX's competition here
BCAT vs MER-PK Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, MER-PK has a market cap of 192.7B. Regarding current trading prices, BCAT is priced at $15.52, while MER-PK trades at $25.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas MER-PK's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to MER-PK's ROE of +0.08%. Regarding short-term risk, BCAT is more volatile compared to MER-PK. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check MER-PK's competition here
BCAT vs IEFA Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, IEFA has a market cap of 181.9B. Regarding current trading prices, BCAT is priced at $15.52, while IEFA trades at $97.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas IEFA's P/E ratio is 18.38. In terms of profitability, BCAT's ROE is +0.13%, compared to IEFA's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to IEFA. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check IEFA's competition here
BCAT vs VB Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VB has a market cap of 180B. Regarding current trading prices, BCAT is priced at $15.52, while VB trades at $289.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VB's P/E ratio is 21.58. In terms of profitability, BCAT's ROE is +0.13%, compared to VB's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to VB. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check VB's competition here
BCAT vs RICBX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, RICBX has a market cap of 179.1B. Regarding current trading prices, BCAT is priced at $15.52, while RICBX trades at $67.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas RICBX's P/E ratio is 28.22. In terms of profitability, BCAT's ROE is +0.13%, compared to RICBX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RICBX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RICBX's competition here
BCAT vs CICAX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, CICAX has a market cap of 179.1B. Regarding current trading prices, BCAT is priced at $15.52, while CICAX trades at $67.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas CICAX's P/E ratio is 28.25. In terms of profitability, BCAT's ROE is +0.13%, compared to CICAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to CICAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check CICAX's competition here
BCAT vs AIVSX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, AIVSX has a market cap of 179.1B. Regarding current trading prices, BCAT is priced at $15.52, while AIVSX trades at $67.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas AIVSX's P/E ratio is 28.26. In terms of profitability, BCAT's ROE is +0.13%, compared to AIVSX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to AIVSX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check AIVSX's competition here
BCAT vs RICAX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, RICAX has a market cap of 179.1B. Regarding current trading prices, BCAT is priced at $15.52, while RICAX trades at $66.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas RICAX's P/E ratio is 28.22. In terms of profitability, BCAT's ROE is +0.13%, compared to RICAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RICAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RICAX's competition here
BCAT vs AICFX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, AICFX has a market cap of 178.5B. Regarding current trading prices, BCAT is priced at $15.52, while AICFX trades at $67.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas AICFX's P/E ratio is 28.25. In terms of profitability, BCAT's ROE is +0.13%, compared to AICFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to AICFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check AICFX's competition here
BCAT vs FFICX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, FFICX has a market cap of 178.5B. Regarding current trading prices, BCAT is priced at $15.52, while FFICX trades at $67.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas FFICX's P/E ratio is 28.27. In terms of profitability, BCAT's ROE is +0.13%, compared to FFICX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to FFICX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FFICX's competition here
BCAT vs AICCX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, AICCX has a market cap of 178.5B. Regarding current trading prices, BCAT is priced at $15.52, while AICCX trades at $66.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas AICCX's P/E ratio is 28.23. In terms of profitability, BCAT's ROE is +0.13%, compared to AICCX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to AICCX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check AICCX's competition here
BCAT vs VSCIX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VSCIX has a market cap of 178.4B. Regarding current trading prices, BCAT is priced at $15.52, while VSCIX trades at $138.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VSCIX's P/E ratio is 21.39. In terms of profitability, BCAT's ROE is +0.13%, compared to VSCIX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VSCIX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VSCIX's competition here
BCAT vs VSMAX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VSMAX has a market cap of 178.4B. Regarding current trading prices, BCAT is priced at $15.52, while VSMAX trades at $138.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VSMAX's P/E ratio is 21.39. In terms of profitability, BCAT's ROE is +0.13%, compared to VSMAX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VSMAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VSMAX's competition here
BCAT vs AFIFX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, AFIFX has a market cap of 174B. Regarding current trading prices, BCAT is priced at $15.52, while AFIFX trades at $102.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas AFIFX's P/E ratio is 28.82. In terms of profitability, BCAT's ROE is +0.13%, compared to AFIFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to AFIFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check AFIFX's competition here
BCAT vs RFNCX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, RFNCX has a market cap of 174B. Regarding current trading prices, BCAT is priced at $15.52, while RFNCX trades at $102.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas RFNCX's P/E ratio is 28.81. In terms of profitability, BCAT's ROE is +0.13%, compared to RFNCX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RFNCX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RFNCX's competition here
BCAT vs ANCFX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, ANCFX has a market cap of 174B. Regarding current trading prices, BCAT is priced at $15.52, while ANCFX trades at $102.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas ANCFX's P/E ratio is 28.82. In terms of profitability, BCAT's ROE is +0.13%, compared to ANCFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to ANCFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check ANCFX's competition here
BCAT vs FINFX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, FINFX has a market cap of 173.3B. Regarding current trading prices, BCAT is priced at $15.52, while FINFX trades at $102.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas FINFX's P/E ratio is 28.83. In terms of profitability, BCAT's ROE is +0.13%, compared to FINFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to FINFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FINFX's competition here
BCAT vs CFNAX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, CFNAX has a market cap of 173.3B. Regarding current trading prices, BCAT is priced at $15.52, while CFNAX trades at $102.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas CFNAX's P/E ratio is 28.82. In terms of profitability, BCAT's ROE is +0.13%, compared to CFNAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to CFNAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check CFNAX's competition here
BCAT vs FUNFX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, FUNFX has a market cap of 173.3B. Regarding current trading prices, BCAT is priced at $15.52, while FUNFX trades at $102.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas FUNFX's P/E ratio is 28.83. In terms of profitability, BCAT's ROE is +0.13%, compared to FUNFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to FUNFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FUNFX's competition here
BCAT vs FCNTX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, FCNTX has a market cap of 172.9B. Regarding current trading prices, BCAT is priced at $15.52, while FCNTX trades at $25.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas FCNTX's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to FCNTX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to FCNTX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FCNTX's competition here
BCAT vs FCNKX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, FCNKX has a market cap of 172.7B. Regarding current trading prices, BCAT is priced at $15.52, while FCNKX trades at $25.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas FCNKX's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to FCNKX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to FCNKX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FCNKX's competition here
BCAT vs C-PN Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, C-PN has a market cap of 169.7B. Regarding current trading prices, BCAT is priced at $15.52, while C-PN trades at $29.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas C-PN's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to C-PN's ROE of +0.08%. Regarding short-term risk, BCAT is less volatile compared to C-PN. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check C-PN's competition here
BCAT vs BLK Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, BLK has a market cap of 166.6B. Regarding current trading prices, BCAT is priced at $15.52, while BLK trades at $1,073.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas BLK's P/E ratio is 26.99. In terms of profitability, BCAT's ROE is +0.13%, compared to BLK's ROE of +0.12%. Regarding short-term risk, BCAT is less volatile compared to BLK. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check BLK's competition here
BCAT vs FNPFX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, FNPFX has a market cap of 165.1B. Regarding current trading prices, BCAT is priced at $15.52, while FNPFX trades at $73.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas FNPFX's P/E ratio is 26.63. In terms of profitability, BCAT's ROE is +0.13%, compared to FNPFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to FNPFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FNPFX's competition here
BCAT vs NPFFX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, NPFFX has a market cap of 165B. Regarding current trading prices, BCAT is priced at $15.52, while NPFFX trades at $73.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas NPFFX's P/E ratio is 26.62. In terms of profitability, BCAT's ROE is +0.13%, compared to NPFFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to NPFFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check NPFFX's competition here
BCAT vs RNPGX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, RNPGX has a market cap of 165B. Regarding current trading prices, BCAT is priced at $15.52, while RNPGX trades at $73.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas RNPGX's P/E ratio is 26.63. In terms of profitability, BCAT's ROE is +0.13%, compared to RNPGX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RNPGX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RNPGX's competition here
BCAT vs ANWPX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, ANWPX has a market cap of 164.3B. Regarding current trading prices, BCAT is priced at $15.52, while ANWPX trades at $73.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas ANWPX's P/E ratio is 26.62. In terms of profitability, BCAT's ROE is +0.13%, compared to ANWPX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to ANWPX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check ANWPX's competition here
BCAT vs RNPCX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, RNPCX has a market cap of 164.3B. Regarding current trading prices, BCAT is priced at $15.52, while RNPCX trades at $71.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas RNPCX's P/E ratio is 26.61. In terms of profitability, BCAT's ROE is +0.13%, compared to RNPCX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RNPCX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RNPCX's competition here
BCAT vs VWO Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VWO has a market cap of 161.5B. Regarding current trading prices, BCAT is priced at $15.52, while VWO trades at $58.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VWO's P/E ratio is 16.76. In terms of profitability, BCAT's ROE is +0.13%, compared to VWO's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to VWO. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check VWO's competition here
BCAT vs VEMAX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VEMAX has a market cap of 160.1B. Regarding current trading prices, BCAT is priced at $15.52, while VEMAX trades at $48.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VEMAX's P/E ratio is 16.74. In terms of profitability, BCAT's ROE is +0.13%, compared to VEMAX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VEMAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VEMAX's competition here
BCAT vs VEMRX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VEMRX has a market cap of 160.1B. Regarding current trading prices, BCAT is priced at $15.52, while VEMRX trades at $123.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VEMRX's P/E ratio is 16.74. In terms of profitability, BCAT's ROE is +0.13%, compared to VEMRX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VEMRX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VEMRX's competition here
BCAT vs FPMAX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, FPMAX has a market cap of 154.6B. Regarding current trading prices, BCAT is priced at $15.52, while FPMAX trades at $10.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas FPMAX's P/E ratio is N/A. In terms of profitability, BCAT's ROE is +0.13%, compared to FPMAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to FPMAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FPMAX's competition here
BCAT vs IEMG Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, IEMG has a market cap of 153.3B. Regarding current trading prices, BCAT is priced at $15.52, while IEMG trades at $80.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas IEMG's P/E ratio is 17.94. In terms of profitability, BCAT's ROE is +0.13%, compared to IEMG's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to IEMG. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check IEMG's competition here
BCAT vs AWSHX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, AWSHX has a market cap of 153.1B. Regarding current trading prices, BCAT is priced at $15.52, while AWSHX trades at $68.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas AWSHX's P/E ratio is 26.39. In terms of profitability, BCAT's ROE is +0.13%, compared to AWSHX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to AWSHX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check AWSHX's competition here
BCAT vs RWMFX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, RWMFX has a market cap of 153B. Regarding current trading prices, BCAT is priced at $15.52, while RWMFX trades at $68.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas RWMFX's P/E ratio is 26.40. In terms of profitability, BCAT's ROE is +0.13%, compared to RWMFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RWMFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RWMFX's competition here
BCAT vs FWMIX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, FWMIX has a market cap of 152.9B. Regarding current trading prices, BCAT is priced at $15.52, while FWMIX trades at $68.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas FWMIX's P/E ratio is 26.40. In terms of profitability, BCAT's ROE is +0.13%, compared to FWMIX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to FWMIX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FWMIX's competition here
BCAT vs CWMAX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, CWMAX has a market cap of 152.5B. Regarding current trading prices, BCAT is priced at $15.52, while CWMAX trades at $68.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas CWMAX's P/E ratio is 26.39. In terms of profitability, BCAT's ROE is +0.13%, compared to CWMAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to CWMAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check CWMAX's competition here
BCAT vs WSHFX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, WSHFX has a market cap of 152.1B. Regarding current trading prices, BCAT is priced at $15.52, while WSHFX trades at $67.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas WSHFX's P/E ratio is 26.39. In terms of profitability, BCAT's ROE is +0.13%, compared to WSHFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to WSHFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check WSHFX's competition here
BCAT vs WGIFX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, WGIFX has a market cap of 151.9B. Regarding current trading prices, BCAT is priced at $15.52, while WGIFX trades at $80.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas WGIFX's P/E ratio is 24.71. In terms of profitability, BCAT's ROE is +0.13%, compared to WGIFX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to WGIFX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check WGIFX's competition here
BCAT vs GLD Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, GLD has a market cap of 150.5B. Regarding current trading prices, BCAT is priced at $15.52, while GLD trades at $413.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas GLD's P/E ratio is -44.06. In terms of profitability, BCAT's ROE is +0.13%, compared to GLD's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to GLD. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check GLD's competition here
BCAT vs WSHCX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, WSHCX has a market cap of 149.6B. Regarding current trading prices, BCAT is priced at $15.52, while WSHCX trades at $66.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas WSHCX's P/E ratio is 26.36. In terms of profitability, BCAT's ROE is +0.13%, compared to WSHCX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to WSHCX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check WSHCX's competition here
BCAT vs RWMBX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, RWMBX has a market cap of 149.2B. Regarding current trading prices, BCAT is priced at $15.52, while RWMBX trades at $66.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas RWMBX's P/E ratio is 26.36. In terms of profitability, BCAT's ROE is +0.13%, compared to RWMBX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RWMBX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RWMBX's competition here
BCAT vs VGT Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VGT has a market cap of 148.9B. Regarding current trading prices, BCAT is priced at $15.52, while VGT trades at $115.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VGT's P/E ratio is 38.53. In terms of profitability, BCAT's ROE is +0.13%, compared to VGT's ROE of +0.00%. Regarding short-term risk, BCAT is less volatile compared to VGT. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check VGT's competition here
BCAT vs VITAX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, VITAX has a market cap of 147.4B. Regarding current trading prices, BCAT is priced at $15.52, while VITAX trades at $474.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas VITAX's P/E ratio is 38.13. In terms of profitability, BCAT's ROE is +0.13%, compared to VITAX's ROE of +0.00%. Regarding short-term risk, BCAT is more volatile compared to VITAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check VITAX's competition here
BCAT vs FIFAX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, FIFAX has a market cap of 147B. Regarding current trading prices, BCAT is priced at $15.52, while FIFAX trades at $27.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas FIFAX's P/E ratio is 19.43. In terms of profitability, BCAT's ROE is +0.13%, compared to FIFAX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to FIFAX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check FIFAX's competition here
BCAT vs BX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, BX has a market cap of 142.4B. Regarding current trading prices, BCAT is priced at $15.52, while BX trades at $118.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas BX's P/E ratio is 30.39. In terms of profitability, BCAT's ROE is +0.13%, compared to BX's ROE of +0.36%. Regarding short-term risk, BCAT is less volatile compared to BX. This indicates potentially lower risk in terms of short-term price fluctuations for BCAT.Check BX's competition here
BCAT vs RERGX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, RERGX has a market cap of 138.2B. Regarding current trading prices, BCAT is priced at $15.52, while RERGX trades at $65.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas RERGX's P/E ratio is 19.95. In terms of profitability, BCAT's ROE is +0.13%, compared to RERGX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to RERGX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check RERGX's competition here
BCAT vs AEPGX Comparison May 2026
BCAT plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCAT stands at 1.6B. In comparison, AEPGX has a market cap of 138.2B. Regarding current trading prices, BCAT is priced at $15.52, while AEPGX trades at $65.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCAT currently has a P/E ratio of 7.32, whereas AEPGX's P/E ratio is 19.94. In terms of profitability, BCAT's ROE is +0.13%, compared to AEPGX's ROE of N/A. Regarding short-term risk, BCAT is more volatile compared to AEPGX. This indicates potentially higher risk in terms of short-term price fluctuations for BCAT.Check AEPGX's competition here